Menu
×
ADVERTISEMENT
ADVERTISEMENT

Gilead Sciences

Gilead's remdesivir reduces Covid mortality risk: Data

Gilead's remdesivir reduces Covid mortality risk: Data

21 June 2021, 13:43 IST
Gilead's profit rises despite lower HIV drug sales

Gilead's profit rises despite lower HIV drug sales

29 April 2021, 23:50 IST
Gilead to expand availability of Remdesivir in India

Gilead to expand availability of Remdesivir in India

27 April 2021, 07:49 IST
Covid-19 leads to decrease in HIV tests

Covid-19 leads to decrease in HIV tests

01 December 2020, 10:19 IST
WHO advises against Gilead's remdesivir for all hospitalised Covid-19 patients

WHO advises against remdesivir for Covid-19 patients

20 November 2020, 09:00 IST
World's top intensive care body advises against remdesivir for sickest Covid-19 patients

Covid: Top intensive care body against remdesivir use

13 November 2020, 12:56 IST
Russian firm seeks to produce Covid-19 drug without patent

Russian firm seeks to produce Covid drug without patent

02 November 2020, 09:26 IST
Nations mulling Gilead's Covid-19 drug, redesivir, should consider trial flop, too, says WHO

'Nations must consider all Gilead Covid drug trials'

23 October 2020, 20:00 IST
Remdesivir shaved 5 days off Covid-19 recovery time, reduced risk of death in some

Remdesivir cuts 5 days off Covid-19 recovery time

09 October 2020, 10:16 IST
Takeda-led Covid-19 plasma treatment enters clinical trial with first patient

Takeda's Covid plasma treatment enters clinical trial

09 October 2020, 06:22 IST